120 related articles for article (PubMed ID: 33517308)
1. Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery.
Shimoda Y; Fujikawa H; Komori K; Watanabe H; Kano K; Yamada T; Shiozawa M; Morinaga S; Katsumata K; Tsuchida A; Ogata T; Oshima T
Anticancer Res; 2021 Feb; 41(2):1005-1012. PubMed ID: 33517308
[TBL] [Abstract][Full Text] [Related]
2. Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?
Sato S; Kunisaki C; Tanaka Y; Sato K; Miyamoto H; Yukawa N; Kosaka T; Akiyama H; Endo I; Misumi T
Ann Surg Oncol; 2019 Dec; 26(13):4452-4463. PubMed ID: 31529308
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
6. Conversion surgery for stage IV gastric cancer: a multicenter retrospective study.
Kano Y; Ichikawa H; Hanyu T; Muneoka Y; Ishikawa T; Aizawa M; Matsuki A; Yabusaki H; Bamba T; Nakagawa S; Kobayashi K; Kuwabara S; Makino S; Kawachi Y; Naito T; Tani T; Hirukawa H; Tada T; Shimada Y; Sakata J; Wakai T
BMC Surg; 2022 Dec; 22(1):428. PubMed ID: 36517780
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer.
Okubo K; Arigami T; Matsushita D; Uenosono Y; Yanagita S; Kijima T; Tsuruda Y; Noda M; Sasaki K; Mori S; Kurahara H; Ohtsuka T
Anticancer Res; 2021 Nov; 41(11):5643-5649. PubMed ID: 34732437
[TBL] [Abstract][Full Text] [Related]
8. The long-term survival of stage IV gastric cancer patients with conversion therapy.
Yamaguchi K; Yoshida K; Tanahashi T; Takahashi T; Matsuhashi N; Tanaka Y; Tanabe K; Ohdan H
Gastric Cancer; 2018 Mar; 21(2):315-323. PubMed ID: 28616743
[TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with resection of stage IV gastric cancer.
Murata S; Terata N; Eguchi Y; Tani T; Shibata J; Kodama M
Int Surg; 1998; 83(4):283-6. PubMed ID: 10096742
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study.
Nakamura N; Kinami S; Tomita Y; Miyata T; Fujita H; Takamura H; Ueda N; Kosaka T
BMC Cancer; 2020 Apr; 20(1):363. PubMed ID: 32349701
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
14. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
[TBL] [Abstract][Full Text] [Related]
15. SPan-1 is a useful prognostic marker for patients with stage IV gastric cancer who underwent palliative gastrectomy: a retrospective multivariate study.
Kubo N; Ohira M; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Nagahara H; Kimura K; Noda E; Amano R; Yamada N; Yashiro M; Maeda K; Sawada T; Hirakawa K
World J Surg; 2013 Jul; 37(7):1681-7. PubMed ID: 23568246
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
[TBL] [Abstract][Full Text] [Related]
17. The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute.
Yamada N; Akai A; Nomura Y; Tanaka N
World J Surg Oncol; 2016 Mar; 14():79. PubMed ID: 26965446
[TBL] [Abstract][Full Text] [Related]
18. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
19. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
